DOT1L inhibitors, such as EPZ004777 and EPZ5676 (also known as pinometostat), reduce HOXA9 and MEIS1 mRNA level expression and induce differentiation of AML cells [127]. The gene discussed is MEIS1; the disease is acute myeloid leukemia.